Sailer Carl 4

What Happened Carl Sailer, a director of Acurx Pharmaceuticals (ACXP), was granted a stock option award for 2,150 shares on April 20, 2026. The award is recorded as a derivative grant (transaction code A) at an acquisition price of $0.00 (i.e., an option/award rather than a cash purchase). The filing was made on April 22, 2026.

Key Details

• Transaction date: 2026-04-20; Form 4 filed: 2026-04-22 (appears timely).
• Grant: 2,150 shares (stock option award); reported price: $0.00 (derivative).
• Shares owned after transaction: not specified in the public Form 4 filing.
• Footnote: Award granted under the Issuer’s Director Compensation Policy; the options vest on April 20, 2027.
• Transaction type: Award/Grant (A) — not an exercise or sale.

Context This is a routine director compensation grant rather than a market purchase or sale. The options are subject to one-year vesting and do not indicate immediate cash realized or a change in ownership today. Such grants are common for board service and should be viewed as compensation, not an urgent bullish or bearish signal.